Evidence-based cannabis information for adults 50 and older Peer-reviewed citations · Always talk to your doctor or pharmacist · No product sales

Our Mission — CannabisForSeniors.org

Why this site exists, what it covers, what it refuses to do (sell products, accept advertising), and how it fits into the TryCannabis.org network.

Why This Site Exists

Adults over 65 represent the fastest-growing cannabis demographic in the United States. Past-month use among this age group surged from less than 1% in 2006 to 7% by 2023 — a more than sevenfold increase. Among adults 50 and older, 21% used cannabis containing THC at least once in the past year, according to the 2024 University of Michigan/AARP National Poll on Healthy Aging.

Yet the clinical research has not kept pace. Almost no randomized controlled trials have specifically recruited participants over 65. Most evidence is extrapolated from younger adult studies combined with geriatric pharmacokinetic principles. Dosing guidelines exist but are based on expert consensus rather than controlled dose-finding trials in elderly populations.

This evidence gap is the reason CannabisForSeniors.org exists. Older adults are making decisions about cannabis right now — millions already use it — and they deserve evidence-based information that accounts for their unique pharmacological realities: age-related changes in liver metabolism, increased body fat affecting drug storage, an average of five prescription medications that may interact with cannabinoids, and an endocannabinoid system that declines with age.

The First Demographic-Focused Health-Education Site

CannabisForSeniors.org is the first site in the TryCannabis.org Cannabis Education Network built around a specific demographic rather than a geography or topic. It exists because older adults face distinct risks and considerations that general cannabis information does not address — drug interactions with polypharmacy, fall risk, cognitive concerns, and the practical realities of navigating dispensaries, Medicare limitations, and conversations with skeptical physicians.

Editorial Independence

CannabisForSeniors.org operates with complete editorial independence:

  • No product sales. We do not sell cannabis, CBD, or any related products.
  • No advertising. We accept no advertising from dispensaries, brands, or product manufacturers.
  • No industry funding. We have no financial relationships with cannabis companies.
  • No affiliate links. We do not earn commissions from dispensary visits or product purchases.

Every factual claim on this site is traced to a specific study, named clinician, or institutional source. When evidence is weak, we say so. When evidence is absent, we say that too.

Part of the Cannabis Education Network

CannabisForSeniors.org is part of the TryCannabis.org Cannabis Education Network, a family of nonprofit educational sites. Companion sites include:

Three Guiding Principles

Every page on this site is guided by three principles drawn from the evidence:

  1. Consult a knowledgeable provider — not because cannabis requires permission, but because polypharmacy interactions and individual health profiles create risks that a provider can identify and a dispensary budtender cannot.
  2. Start genuinely low — 1 to 2.5 mg of THC is not conservative caution but evidence-based geriatric dosing, and many seniors find therapeutic benefit at doses that produce no perceptible intoxication.
  3. Choose products that match aging bodies — tinctures, low-dose edibles, topicals, and patches offer precision and safety advantages over smoking, vaping, or concentrates.